National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 382750

History of Changes from the VAERS Wayback Machine

First Appeared on 4/7/2010

VAERS ID: 382750
VAERS Form:
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2009-06-08
Onset:2009-06-29
Submitted:2010-03-15
Entered:2010-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Arthritis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1003USA01645

Write-up: Initial case was reported on 09-MAR-2010 by Health Authority (HA ref. DK-DKMA-20094639). It was reported that a 12-year-old female patient with no concurrent illness reported was vaccinated with the first dose GARDASIL (i.m., batch number and site of administration not reported) on 08-JUN-2009. No concomitant medicine was reported. It was reported that the patient developed intermitting episodes of arthritis in the large joints 3 weeks post vaccination. It was reported that each episode of arthritis lasted for 3-5 days and that the patient was symptom free for 1 week, before the symptoms returned. It was reported that the patient had not recovered. The patient''s arthritis was considered to be disabling by reporter. Other business partner numbers include E2010-0558. No further information is available.


Changed on 6/14/2014

VAERS ID: 382750 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2009-06-08
Onset:2009-06-29
Submitted:2010-03-15
Entered:2010-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Arthritis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1003USA01645

Write-up: Initial case was reported on 09-MAR-2010 by Health Authority (HA ref. DK-DKMA-20094639). It was reported that a 12-year-old female patient with no concurrent illness reported was vaccinated with the first dose GARDASIL (i.m., batch number and site of administration not reported) on 08-JUN-2009. No concomitant medicine was reported. It was reported that the patient developed intermitting episodes of arthritis in the large joints 3 weeks post vaccination. It was reported that each episode of arthritis lasted for 3-5 days and that the patient was symptom free for 1 week, before the symptoms returned. It was reported that the patient had not recovered. The patient''s arthritis was considered to be disabling by reporter. Other business partner numbers include E2010-0558. No further information is available.


Changed on 4/14/2017

VAERS ID: 382750 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2009-06-08
Onset:2009-06-29
Submitted:2010-03-15
Entered:2010-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Arthritis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1003USA01645

Write-up: Initial case was reported on 09-MAR-2010 by Health Authority (HA ref. DK-DKMA-20094639). It was reported that a 12-year-old female patient with no concurrent illness reported was vaccinated with the first dose GARDASIL (i.m., batch number and site of administration not reported) on 08-JUN-2009. No concomitant medicine was reported. It was reported that the patient developed intermitting episodes of arthritis in the large joints 3 weeks post vaccination. It was reported that each episode of arthritis lasted for 3-5 days and that the patient was symptom free for 1 week, before the symptoms returned. It was reported that the patient had not recovered. The patient''s arthritis was considered to be disabling by reporter. Other business partner numbers include E2010-0558. No further information is available.


Changed on 9/14/2017

VAERS ID: 382750 Before After
VAERS Form:(blank) 1
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2009-06-08
Onset:2009-06-29
Submitted:2010-03-15
Entered:2010-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 1 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Arthritis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1003USA01645

Write-up: Initial case was reported on 09-MAR-2010 by Health Authority (HA ref. DK-DKMA-20094639). It was reported that a 12-year-old female patient with no concurrent illness reported was vaccinated with the first dose GARDASIL (i.m., batch number and site of administration not reported) on 08-JUN-2009. No concomitant medicine was reported. It was reported that the patient developed intermitting episodes of arthritis in the large joints 3 weeks post vaccination. It was reported that each episode of arthritis lasted for 3-5 days and that the patient was symptom free for 1 week, before the symptoms returned. It was reported that the patient had not recovered. The patient''s arthritis was considered to be disabling by reporter. Other business partner numbers include E2010-0558. No further information is available.


Changed on 2/14/2018

VAERS ID: 382750 Before After
VAERS Form:1
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2009-06-08
Onset:2009-06-29
Submitted:2010-03-15
Entered:2010-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Arthritis

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1003USA01645

Write-up: Initial case was reported on 09-MAR-2010 by Health Authority (HA ref. DK-DKMA-20094639). It was reported that a 12-year-old female patient with no concurrent illness reported was vaccinated with the first dose GARDASIL (i.m., batch number and site of administration not reported) on 08-JUN-2009. No concomitant medicine was reported. It was reported that the patient developed intermitting episodes of arthritis in the large joints 3 weeks post vaccination. It was reported that each episode of arthritis lasted for 3-5 days and that the patient was symptom free for 1 week, before the symptoms returned. It was reported that the patient had not recovered. The patient''s arthritis was considered to be disabling by reporter. Other business partner numbers include E2010-0558. No further information is available.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=382750&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166